This is a preview of subscription content, log in via an institution to check access.
Data Availability
Data from Simons Searchlight can be obtained directly by request from SFARI Base through at https://base.sfari.org. Data from the Children’s Hospital of Colorado is available from the corresponding author upon request.
References
Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med. 2008;358(7):667–75.
Chung WK, Roberts TP, Sherr EH, Snyder LG, Spiro JE. 16p11.2 deletion syndrome. Curr Opin Genet Dev. 2021;68:49–56.
Fernandez BA, Roberts W, Chung B, Weksberg R, Meyn S, Szatmari P, et al. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J Med Genet. 2010;47(3):195–203.
Shiow LR, Paris K, Akana MC, Cyster JG, Sorensen RU, Puck JM. Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion. Clin Immunol. 2009;131(1):24–30.
Maggadottir SM, Li J, Glessner JT, Li YR, Wei Z, Chang X, et al. Rare variants at 16p11.2 are associated with common variable immunodeficiency. J Allergy Clin Immunol. 2015;135(6):1569–77.
Bachmann-Gagescu R, Mefford HC, Cowan C, Glew GM, Hing AV, Wallace S, et al. Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity. Genet Med. 2010;12(10):641–7.
Acknowledgements
We are grateful to all of the families at the participating Simons Searchlight sites as well as the Simons Searchlight Consortium, formerly the Simons VIP Consortium. We appreciate obtaining access to phenotypic data on SFARI Base. Approved researchers can obtain the Simons Searchlight population dataset described in this study by applying at https://base.sfari.org.
Author information
Authors and Affiliations
Contributions
All authors (LAW, AL, JKA) contributed to the study conception and design. Material preparation, data collection, and analysis were performed by LAW and JKA. The first draft of the manuscript was written by LAW and all authors (LAW, AL, JKA) commented on previous versions of the manuscript. All authors (LAW, AL, JKA) read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval
This study was approved by the Colorado Multiple Institutional Review Board.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, L.A., Larson, A. & Abbott, J.K. The Immune Status of Patients with 16p11.2 Deletion Syndrome. J Clin Immunol 43, 1792–1795 (2023). https://doi.org/10.1007/s10875-023-01597-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-023-01597-2